Search

Search Constraints

You searched for: Author/Creator Bachmann, Felix

Search Results

2. Derazantinib: an investigational drug for the treatment of cholangiocarcinoma. (2nd November 2021)

3. Overexpression of eIF3a in Squamous Cell Carcinoma of the Oral Cavity and Its Putative Relation to Chemotherapy Response. (23rd April 2012)

4. Preclinical modeling in glioblastoma patient-derived xenograft (GBM PDX) xenografts to guide clinical development of lisavanbulin—a novel tumor checkpoint controller targeting microtubules. Issue 3 (7th July 2021)

6. The fibroblast growth factor receptor inhibitor, derazantinib, has strong efficacy in human gastric tumor models and synergizes with paclitaxel in vivo. Issue 4 (2nd April 2023)

7. The novel microtubule targeting agent BAL101553 in combination with radiotherapy in treatment-refractory tumor models. Issue 3 (September 2017)